論文発表　2022年

原著論文

1. Kazuchika Nishitsuji, Midori Ikezaki, Shino Manabe, Kenji Uchimura, Yukishige Ito, Yoshito Ihara, “Thrombospondin type 1 repeat‑derived C‑mannosylated peptide attenuates synaptogenesis of cortical neurons induced by primary astrocytes via TGF‑β”, Glycoconj. J. in press. doi: 10.1007/s10719-021-10030-y.
2. Kazunobu Ohnuki, Mitsuyoshi Yoshimoto, Hiromitsu Haba, Shino Manabe, Hiroki Takashima, Masahiro Yasunaga, Hirofumi Fujii, “Protection from contamination by 211At, an enigmatic but promising alpha emitter” EJNMMI Physics, 9, 39 (2002) doi.org/10.1186/s40658‐022‐00469‐9
3. Midori Ikezaki, Kazuchika Nishitsuji, Ko Matsumura, Shino Manabe, Yukinao Shibukawa, Yoshinao Wada, Yukishige Ito, Yoshito Ihara, “C-Mannosylated tryptophan-containing peptide binds 1 to actinin-4 and suppresses E2 cadherin-dependent cell-cell interactions in lung epithelial-like A549 cells”, Biochimie, in press. doi:10.1016/j.biochi.2021.10.007

総説

1. 眞鍋史乃、安永正浩「抗体薬物複合体 (ADC) の設計：breakthrough と課題」腫瘍内科、in press.
2. 眞鍋史乃、「糖鎖連結抗体・薬物複合体作製による抗体機能増強」、実験医学増刷「新たな時代を迎えた抗体医薬」、津本浩平著、in press.
3. 眞鍋史乃、「抗体―薬物複合体開発の発展と現状：ドラッグデリバリーシステムの改良による抗悪性腫瘍薬の効果増強」メディカルレビュ―、19, 12-15 (2022).